Precede Biosciences
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- $121M
Investors
- 13
About Precede Biosciences
Founded in 2021 and based in Massachusetts, US, Precede Biosciences, Inc. is a designer of advanced precision medicine with liquid biopsy technology. The company was co-founded by its CEO, Rehan Verjee. In January 2026, Precede Biosciences, Inc. The company develops a liquid biopsy platform that reveals actionable disease-defining transcriptional biology through a minimally invasive blood test. The firm’s platform profiles circulating chromatin and DNA methylomes from just 1 mL of plasma. This genome-wide analysis provides insights into the activation of individual genes and pathways. Precede Biosciences' approach analyzes DNA methylomes from plasma and circulating chromatin, giving researchers and physicians an understanding of how specific genes and pathways are dynamically activated in sick tissues.
Who invested in Precede Biosciences
13 investors across 3 rounds
See all investors in Precede Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Precede Biosciences
Who invested in Precede Biosciences?
Precede Biosciences has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Precede Biosciences raised?
Precede Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Precede Biosciences last raise money?
Precede Biosciences's most recent round on record is a Series B, in Jan 2026.
What does Precede Biosciences do?
Founded in 2021 and based in Massachusetts, US, Precede Biosciences, Inc.
Where is Precede Biosciences headquartered?
Precede Biosciences is headquartered in Boston, US.
Which VCs invest in companies like Precede Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Precede Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Precede Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.